SOPHiA GENETICS Competitors and Similar CompaniesClear all
SOPHiA GENETICS's competitors and similar companies include Exscientia, Genomic Health, Veracyte and Guardant Health.
 SOPHiA GENETICS SOPHiA GENETICS is a healthcare technology company focused on establishing the practice of data-driven medicine. |  Exscientia Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery. |  Genomic Health Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests. |  Veracyte Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer. |  Guardant Health Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy. | |
Founding Date | Founding Date 2011 | Founding Date 2012 | Founding Date 2000 | Founding Date 2008 | Founding Date 2012 |
Type | Type Public | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Rolle, CH HQ Bidart, FR Boston, US | Locations Oxford, GB HQ Wien, AT Osaka, JP Dundee, GB Miami, US | Locations Redwood City, US HQ Köln, DE Chiyoda City, JP London, GB | Locations South San Francisco, US HQ Marseille, FR Haifa, IL Austin, US San Diego, US | Locations Redwood City, US HQ |
Employees | Employees 423 | Employees 88 | Employees 311 | Employees 8154% increase | Employees 1,7681% decrease |
Valuation ($) | Valuation ($) 236.4 m | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 2.6 b | Valuation ($) 2.7 b |
Financial | |||||
Revenue (est.) | Revenue (est.) $77.3m (FY, 2025) | Revenue (est.) £20.1m (FY, 2023) | Revenue (est.) $394.1m (FY, 2018) | Revenue (est.) $517.1m (FY, 2025) | Revenue (est.) $982m (FY, 2025) |
Cost of goods | Cost of goods $19.9m (FY, 2025) | Cost of goods £10.5m (FY, 2023) | Cost of goods N/A | Cost of goods N/A | Cost of goods $349m (FY, 2025) |
Gross profit | Gross profit $57.4m (FY, 2025) | Gross profit £10.8m (FY, 2023) | Gross profit N/A | Gross profit $362.5m (FY, 2025) | Gross profit $633m (FY, 2025) |
Net income | Net income ($79m) (FY, 2025) | Net income (£146m) (FY, 2023) | Net income $25.7m (FY, 2018) | Net income $66.4m (FY, 2025) | Net income ($416.3m) (FY, 2025) |
Funding | |||||
Total funding raised | Total funding raised $ 245.8m | Total funding raised $ 430.2m | Total funding raised N/A | Total funding raised $ 116.3m | Total funding raised $ 550m |
For sources of this data, please see the company profile
View Company Profiles
Exscientia
HQ
Oxford, GB
Exscientia is a pharmatech company that utilizes artificial intelligence for small molecule drug discovery.
View companyGenomic Health
HQ
Redwood City, US
Genomic Health is a company that provides actionable genomic information to personalize cancer treatment decisions via the Oncotype DX tests.
View companyVeracyte
HQ
South San Francisco, US
Employees
815↑ 4% increase
Veracyte (formerly known as Calderome) is a genomic diagnostics company that specializes in molecular testing for the treatment of cancer.
View companyGuardant Health
HQ
Redwood City, US
Employees
1,768↓ 1% decrease
Guardant Health is a company that specializes in non-invasive cancer diagnostics and comprehensive genomic liquid biopsy.
View company